Equity-Based Compensation Rollforward (Detail) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares
RSUs
Remaining Contractual Life and Aggregate Intrinsic Value
Outstanding at end of period (Aggregate Intrinsic Value) | $	$ 153,691
Vested, but not issued at end of period (Aggregate Intrinsic Value) | $	$ 26,550
Employee Stock
Stock Option, Shares
Outstanding at beginning of period (Shares) | shares	534,695
Granted (Shares) | shares	177,486
Exercised (Shares) | shares	(95,069)
Forfeited (Shares) | shares	(26,558)
Outstanding at end of period (Shares) | shares	590,554
Exercisable at end of period (Shares) | shares	317,019
Weighted Average Per Share Exercise Price
Outstanding at beginning of period (Weighted Average Exercise Price) | $ / shares	$ 2,424.62
Granted (Weighted Average Exercise Price) | $ / shares	4,478.88
Exercised (Weighted Average Exercise Price) | $ / shares	2,068.6
Forfeited (Weighted Average Exercise Price) | $ / shares	3,283.34
Outstanding at end of period (Weighted Average Exercise Price) | $ / shares	3,060.71
Exercisable at end of period (Weighted Average Exercise Price) | $ / shares	$ 2,201.66
Remaining Contractual Life and Aggregate Intrinsic Value
Outstanding at end of period (Weighted Average Remaining Contract Life (Years)	5 years 10 months 24 days
Exercisable at end of period (Weighted Average Remaining Contract Life (Years)	3 years 9 months 18 days
Outstanding at end of period (Aggregate Intrinsic Value) | $	$ 917,424
Exercisable at end of period (Aggregate Intrinsic Value) | $	$ 764,250